U.S., June 23 -- ClinicalTrials.gov registry received information related to the study (NCT07661641) titled 'A Study of [177Lu]Lu-A9-0631 and [225Ac]Ac-A9-0642 With [68Ga]Ga-A9-6217 or [177Lu]Lu-A9-0631 Imaging in GRPR+ Solid Tumors' on June 09.
Brief Summary: This is a Phase 1-1b multicenter clinical study to evaluate the safety, efficacy, and dosimetry of [177Lu]Lu-A9-0631 and [225Ac]Ac-0642 in participants with Gastrin-Releasing Peptide Receptor (GRPR) expressing locally advanced, unresectable or metastatic solid tumors.
Study Start Date: July 01
Study Type: INTERVENTIONAL
Condition:
Breast Cancer
Prostate Cancer
Colorectal Cancer
GRPR-positive Solid Tumors
Intervention:
DIAGNOSTIC_TEST: [68Ga]Ga-A9-6217
Administered IV
DIAGNOST...